Suppr超能文献

美普他酚与吗啡或氧化震颤素之间的交叉耐受性研究。

Meptazinol cross-tolerance studies between morphine or oxotremorine.

作者信息

Bensreti M M, Gonzalez J P, Sewell R D

出版信息

Neuropeptides. 1984 Dec;5(1-3):33-6. doi: 10.1016/0143-4179(84)90020-9.

Abstract

The time course of the development of auto-tolerance to meptazinol as determined by combined heat and pressure nociceptive tests has been examined using two dose levels of meptazinol (10 mg and 30 mgkg-1s.c.) corresponding to the partial agonist and cholinergic components respectively. In mice treated twice daily with meptazinol for eight days, there was cross tolerance to morphine in both tests at each dose level of meptazinol. In chronic morphine treated mice challenged with meptazinol (30 mg kg-1 s.c.), there was no cross tolerance with morphine since meptazinol still retained its antinociceptive effects in both tests. Mice treated chronically with meptazinol (30 mgkg-1 s.c.) did not respond to the cholinomimetic agent oxotremorine, implying that there was cross tolerance between these two analgesics. These data suggest the existence of a one-way tolerance between morphine and meptazinol whilst at higher doses of meptazinol a full tolerance occurs with oxotremorine.

摘要

通过热和压力伤害感受测试组合来确定对美普他酚自身耐受性发展的时间进程,已使用分别对应部分激动剂和胆碱能成分的两个剂量水平的美普他酚(10毫克和30毫克/千克皮下注射)进行了研究。在用美普他酚每日两次处理八天的小鼠中,在美普他酚的每个剂量水平的两种测试中均存在对吗啡的交叉耐受性。在用美普他酚(30毫克/千克皮下注射)激发的慢性吗啡处理小鼠中,不存在与吗啡的交叉耐受性,因为美普他酚在两种测试中仍保留其抗伤害感受作用。用美普他酚(30毫克/千克皮下注射)长期处理的小鼠对拟胆碱药氧化震颤素无反应,这意味着这两种镇痛药之间存在交叉耐受性。这些数据表明吗啡和美普他酚之间存在单向耐受性,而在较高剂量的美普他酚时,对氧化震颤素会出现完全耐受性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验